Pfizer, Schering Sign License Deal
445972
Pfizer Inc. has agreed to license a  set of potential drugs for the prevention of stroke and heart  attacks from Germany's Schering, the two companies said on  Wednesday.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.
609083
It&#39;s too late for this year&#39;s flu season, but a Canadian drug company yesterday said it has agreed to provide influenza vaccines to Henry Schein Inc.
160780
Roche Holding, the world&#39;s biggest maker of diagnostic tests, has received Food and Drug Administration approval to market the first laboratory gene test that can help doctors reduce the risk of side effects for certain medications.
24676
Bayer AG forged an alliance for its struggling pharmaceuticals business with US drugmaker Schering-Plough on Monday, cutting costs and marking another step in the German company&#39;s transformation.
643039
Drug giant Schering-Plough Corp. said Monday that it will pay $10 million to exercise its option to license ViroPharma Inc.&#39;s cold treatment in the United States and Canada.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
750251
BOSTON (CBS.MW) -- Pharmaceutical conglomerates Schering-Plough and Bayer have entered into a broad joint-marketing deal Monday for several of the companies&#39; leading drugs.
296490
The small pharmaceutical firm signs another big deal.
611168
Schering-Plough Corp. said Monday it will buy the pharmaceuticals division of Akzo Nobel NV for 11 billion euros ($14.5 billion) in cash, acquiring the Organon brand of birth control and strengthening its drug pipeline with an anti-schizophrenia medication.
456207
Dutch chemical group Akzo Nobel NV   said on Monday it is selling its  pharmaceutical unit Organon BioSciences to Schering-Plough   for 11 billion euros ($14.5 billion).
691450
BERLIN -- German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced Monday they have entered a strategic alliance under which Schering-Plough will distribute
507533
ID Biomedical Corp. IDB.TO IDBE.O  signed a 10-year U.S. distribution deal for its Fluviral drug  that could reap sales of $2.3 billion and help U.S. authorities  fill a flu vaccine shortage, the company said on Monday.
502540
Johnson & Johnson  and Pfizer Inc.  have agreed to sell the U.S. rights to five brands, including anti-diarrhea drug Kaopectate, to Chattem Inc.  for $410 million to satisfy regulatory requirements, Chattem said on Friday.
205867
German drug maker Schering, recently acquired by pharmaceuticals and chemicals giant Bayer, has said that it was teaming up with British drug giant AstraZeneca to develop a new treatment against breast cancer.
63189
Bayer forged an alliance for its struggling pharmaceuticals business with American drug manufacturer Schering-Plough yesterday, cutting costs and marking another step in the German company&#39;s transformation.
719489
Pfizer Inc. said on Monday it had  reached a definitive agreement to sell its consumer healthcare  business to Johnson &amp; Johnson for &#36;16.6 billion in cash.